Results 231 to 240 of about 122,604 (290)

When Breast Cancer Meets the Uterus: A Quantitative Review of 105 Cases Spanning Four Decades. [PDF]

Medicina (Kaunas)
Georgescu TA, Georgescu AC, Olinca MV.
europepmc   +1 more source

Toremifene-induced bilateral macular crystalline deposits with cystic cavitation: a case report. [PDF]

Front Med (Lausanne)
Niu C, Wang F, Li J, Sun X, Xie X, Gao Y.   +5 more
europepmc   +1 more source

Design-Expert^® Optimization of Tamoxifen-Loaded Transethosomal Gels: A Promising Transdermal System with Cytotoxicity and Stability Validation. [PDF]

Pharmaceutics
Abou Assi R, Farhan AB, Darweesh KA, Hassan AH, Chan SY.   +4 more
europepmc   +1 more source

Risk of osteoporosis and fracture among patients with breast cancer: a systematic review and meta-analysis of cohort studies. [PDF]

Front Oncol
Li K, Qian Y, Cao Y.
europepmc   +1 more source

Impact of Tamoxifen Only After Lumpectomy for "Good-Risk" Duct Carcinoma In Situ: Combined Analysis of the NRG Oncology/RTOG 9804 and ECOG-ACRIN E5194 Trials. [PDF]

Int J Radiat Oncol Biol Phys
Wright JL, Moughan J, Woodward WA, Rahbar H, Shah AB, Comstock C, Jarvis LA, Tjoe JA, Germain I, Badve SS, Strom E, Recht A, Ling DC, Vallow LA, Stephenson JJ, Currey A, Walker EM, Reiter H, Steinberg ML, Pierce LJ, Winter K, Sparano J, Davidson NE, Wolff A, Mamounas EP, White JR, McCormick B.   +26 more
europepmc   +1 more source

The effectiveness of hormonal treatment to improve reproductive outcomes in normogonadotropic men with abnormal semen parameters: results of 2 linked systematic reviews.

J Clin Endocrinol Metab
Konnyu K, Imamura M, Hudson J, Swingler J, Manson P, Bhattacharya S, Jayasena CN, Brazzelli M.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Tamoxifen and Hypercalcemia

Annals of Internal Medicine, 1978
Excerpt To the editor: To prove that tamoxifen causes hypercalcemia in advanced breast cancer, as has been suggested by Veldhuis (1) and others (2-4), would require that three criteria be met.
K I, Pritchard, R M, Clark, S, Fine, J W, Meakin, D J, Perrault, D J, Sutherland   +5 more
  +7 more sources

Tamoxifen retinopathy

Survey of Ophthalmology, 2023
Tamoxifen (TAM) is a selective estrogen receptor modulator that is used in the treatment of breast cancer. As there are estrogen receptors in the retina, retinal pigment epithelium, and choroid, these tissues may also be affected by TAM. We describe the reported effects of TAM on the retina and choroid.
Fatemeh Bazvand, Zahra Mahdizad, Nader Mohammadi, Farhad Shahi, Masoud Mirghorbani, Hamid Riazi-Esfahani, Bobeck S. Modjtahedi   +6 more
openaire   +2 more sources

Tamoxifen and Oligospermia

Archives of Andrology, 1985
Thirty normogonadotropic oligospermic males were administered Tamoxifen (20 mg/day) for 4 months. A complete evaluation of seminal parameters before and after treatment was performed. An increase of both mean sperm concentration and total sperm count was noted after treatment with Tamoxifen (p less than 0.05), whereas no variation was observed for ...
I, Noci, E, Chelo, O, Saltarelli, G, Donati Cori, G, Scarselli   +4 more
openaire   +2 more sources

Tamoxifen and pregnancy

Breast, 2004
Women are conventionally advised to stop tamoxifen before attempting pregnancy. The risks of congenital malformations or late teratogenic manifestations in adulthood are unknown. Following an informed discussion about the uncertainties of tamoxifen exposure on pregnancy women should be offered the choice whether to continue or stop tamoxifen before ...
L, Barthelmes, C A, Gateley
exaly   +3 more sources